HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats--studies in the isolated perfused hydronephrotic kidney.

Abstract
The present study examined the role of L-/T-type Ca channels and the interaction between these channels and protein kinase C (PKC) in hypertension. The isolated perfused hydronephrotic rat kidney model was used to visualize directly the renal microvascular effects of L-/T-type Ca channel blockers (nifedipine and mibefradil, respectively). Nifedipine reversed the angiotensin II-induced constriction of afferent, but not efferent, arterioles in kidneys from Wistar-Kyoto rats (WKY), and similar magnitude in dilation was observed in spontaneously hypertensive rats (SHR). Although mibefradil elicited dilation of both arterioles, the afferent arteriolar dilation was less in SHR than in WKY (57+/-5% vs. 80+/-4% reversal at 1 micrommol/L). The pretreatment with staurosporine did not alter the angiotensin II-induced afferent arteriolar constriction in WKY, but attenuated this response in SHR. Furthermore, staurosporine enhanced the nifedipine-induced afferent arteriolar dilation (62+/-3% vs. 50+/-3% reversal at 10 nmol/L), and restored the attenuated afferent arteriolar response to mibefradil in SHR. The pretreatment with thapsigargin (a blocker of IP3-mediated intracellular calcium release) prevented the angiotensin II-induced afferent arteriolar constriction in WKY, but caused a significant constriction of afferent arterioles in SHR and efferent arterioles in WKY and SHR; in this setting, mibefradil did not alter efferent arteriolar tone. In conclusion, although both L-type (nifedipine) and T-type Ca channel blockers (mibefradil) exerted potent vasodilation of rat renal microvessels, these actions were modified by PKC, which determined the afferent arteriolar sensitivity to these blockers in SHR. Furthermore, the enhancement in nifedipine-induced afferent arteriolar dilation by staurosporine in SHR suggests that L-type Ca channel activity is augmented in hypertensive animals.
AuthorsKoichi Hayashi, Shu Wakino, Yuri Ozawa, Koichiro Homma, Takeshi Kanda, Ken Okubo, Ichiro Takamatsu, Satoru Tatematsu, Hiroo Kumagai, Takao Saruta
JournalThe Keio journal of medicine (Keio J Med) Vol. 54 Issue 2 Pg. 102-8 (Jun 2005) ISSN: 0022-9717 [Print] Japan
PMID16077260 (Publication Type: Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Calcium Channels
  • Enzyme Inhibitors
  • Vasodilator Agents
  • Angiotensin II
  • Mibefradil
  • Thapsigargin
  • Protein Kinase C
  • Staurosporine
  • Nifedipine
  • Calcium
Topics
  • Angiotensin II (metabolism)
  • Animals
  • Arterioles (metabolism)
  • Calcium (metabolism)
  • Calcium Channel Blockers (metabolism, pharmacology)
  • Calcium Channels (metabolism)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (pharmacology)
  • Hydronephrosis (pathology)
  • Hypertension (pathology)
  • Kidney (blood supply, metabolism)
  • Male
  • Mibefradil (pharmacology)
  • Microcirculation
  • Nifedipine (pharmacology)
  • Perfusion
  • Protein Kinase C (metabolism, physiology)
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Staurosporine (metabolism, pharmacology)
  • Thapsigargin (metabolism, pharmacology)
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: